DocMorris AG reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CHF 462.96 million compared to CHF 494.65 million a year ago. Net income was CHF 141.61 million compared to net loss of CHF 86.09 million a year ago.

Basic loss per share from continuing operations was CHF 4.98 compared to CHF 8.05 a year ago. Diluted loss per share from continuing operations was CHF 4.98 compared to CHF 8.05 a year ago. Basic earnings per share was CHF 12.12 compared to basic loss per share of CHF 8.29 a year ago.

Diluted earnings per share was CHF 12.12 compared to diluted loss per share of CHF 8.29 a year ago.